← Leaderboards
Russell T Hepple
California Pacific Med Ctr Res Institute
$14,589,506
Attributed
$60,464,009
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.6M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$60,464,009 · 5
By mechanism
R01$56,705,926 · 2
R56$3,421,598 · 2
R21$336,485 · 1
Top collaborators
- Steven R Cummings10 shared
- Stephen B Kritchevsky10 shared
- Anne B Newman9 shared
- Terence E Ryan4 shared
- Bret H. Goodpaster3 shared
- Nancy W Glynn1 shared
Most similar at California Pacific Med Ctr Res Institute
Same institution · by research overlap
- Gregory J. Tranah$6,422,039
- Leon Lenchik$684,137
- Daniel Spencer Evans$1,539,983
Others in their field
Other Emerging Leaders on “Muscle”
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Ian R Lanza · Mayo Clinic Rochester$11,741,175
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- James Even Voss · Scripps Research Institute, The$8,943,702
- Fritzie Isip Arce-McShane · University Of Chicago$8,435,878
- Elizabeth Marjorie Cespedes Feliciano · Columbia University Health Sciences$6,865,794
Research focus
MuscleMitochondriaBloodAgingPathway InteractionsMuscle FormSkeletal MuscleElderlyMuscular AtrophyImpairmentMuscle AgingDenervationTissuesDisabilityBiopsyPreventPropertyWalking SpeedAge RelatedQuality Of LifeRecruitDependenceBiologicalLink
Grant awards (17)
Study of Muscle, Mobility and Aging: SOMMA2$14,954,746
R01 · FY2025 · AG
Linking kynurenine accumulation and the AHR pathway to exacerbated aging$493,542
R01 · FY2025 · AG
Targeting mitochondrial permeability transition to attenuate adverse muscle impact in sepsis$143,297
R21 · FY2025 · AR · contact PI
Study of Muscle, Mobility and Aging: SOMMA2$12,573,238
R01 · FY2024 · AG
Linking kynurenine accumulation and the AHR pathway to exacerbated aging$499,863
R01 · FY2024 · AG
Targeting mitochondrial permeability transition to attenuate adverse muscle impact in sepsis$193,188
R21 · FY2024 · AR · contact PI
Study of Muscle, Mobility and Aging: SOMMA2$3,108,973
R56 · FY2023 · AG
Linking kynurenine accumulation and the AHR pathway to exacerbated aging$569,891
R01 · FY2023 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,132,942
R01 · FY2022 · AG
Linking kynurenine accumulation and the AHR pathway to exacerbated aging$510,779
R01 · FY2022 · AG
Study of Muscle, Mobility and Aging (SOMMA)$245,474
R01 · FY2022 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,122,495
R01 · FY2021 · AG
Mitochondrial Permeability Transitionin Aging Muscle$312,625
R56 · FY2021 · AG · contact PI
Study of Muscle, Mobility and Aging (SOMMA)$4,001,503
R01 · FY2020 · AG
SOMMA-BRAIN$325,698
R01 · FY2020 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,818,929
R01 · FY2019 · AG
Study of Muscle, Mobility and Aging (SOMMA)$6,456,826
R01 · FY2018 · AG